Physician profile
Jane Johansson
NPI 1821353350
$904.93
in general payments reported to CMS, 2019-2025
19 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $91.51 · 2024: $266 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616 · Education: $77.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.10 |
| Education | $77.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $235.52 | 2021-2025 | Rybrevant |
| Avanos Medical | $138.99 | 2024-2025 | Genvisc 850 Sodium Hyaluronate |
| Seagen INC. | $77.99 | 2025 | |
| Incyte Corporation | $69.73 | 2025 | Zynyz, Monjuvi, Jakafi |
| Bioventus LLC | $54.50 | 2024 | Gelsyn-3 |
| Emd Serono, INC. | $45.97 | 2025 | |
| Ferring Pharmaceuticals INC. | $27.05 | 2024 | Euflexxa |
| Gilead Sciences, INC. | $27.01 | 2024 | |
| Novartis Pharmaceuticals Corporation | $26.65 | 2025 | |
| Cgg Medical INC | $26.51 | 2024 | |
| Exact Sciences Corporation | $22.80 | 2024 | Cologuard Collection Kit |
| Taiho Oncology, INC. | $22.14 | 2025 | |
| Genzyme Corporation | $21.71 | 2025 | |
| Daiichi Sankyo INC. | $20.74 | 2025 | Datroway |
| Ipsen Biopharmaceuticals, INC | $19.12 | 2025 | Somatuline Depot, Onivyde |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.83 | 2025 | Reblozyl, Keytruda, Welireg |
| Pfizer INC. | $18.75 | 2024 | |
| Lilly USA, LLC | $16.38 | 2025 | Mounjaro |
| Legend Biotech USA INC. | $14.54 | 2025 | Carvykti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Johansson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.